Unactivated alkylsulfinic acids as an alkyl radical source for the synthesis of 3,3-dialkylindolin-2-ones an electron donor-acceptor complex

Using unactivated alkylsulfinic acids as an alkyl radical source, a novel and highly practical visible-light-assisted synthetic methodology for the alkylation/annulation of a series of N -arylacrylamides into corresponding 3,3-dialkylindolin-2-ones has been developed. This approach does not require...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:New journal of chemistry 2024-10, Vol.48 (39), p.1797-1715
Hauptverfasser: Natarajan, Palani, Partigya, Meena
Format: Artikel
Sprache:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Using unactivated alkylsulfinic acids as an alkyl radical source, a novel and highly practical visible-light-assisted synthetic methodology for the alkylation/annulation of a series of N -arylacrylamides into corresponding 3,3-dialkylindolin-2-ones has been developed. This approach does not require a photosensitizer or any metal reagents because the development of an electron donor-acceptor complex between alkylsulfinates and 2-isocyano-1,1′-biphenyl (catalytic electron acceptor) allows, under visible-light irradiation, the preparation of desired products in good yields. The mildness, gram-scale synthesizability, no need for the use of toxic organic solvents and a transition metal, as well as suitability for the synthesis of bioactive compounds (used as progesterone antagonists and anti-depressants) are a few noteworthy features of this procedure. Furthermore, alkylsulfinic acids are stable, safe, easy to handle, and readily available compared to other alkyl radical donors (like N -(acyloxy)phthalimides and Katritzky salts) reported in the literature. Using unactivated alkylsulfinic acids as an alkyl radical source, a visible-light-assisted method for the alkylation/annulation of N -arylacrylamides has been developed. It is also suitable for the synthesis of progesterone antagonists and amedalin.
ISSN:1144-0546
1369-9261
DOI:10.1039/d4nj03602f